BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30388364)

  • 1. Dynamics and Molecular Mechanisms of p53 Transcriptional Activation.
    Offutt TL; Ieong PU; Demir Ö; Amaro RE
    Biochemistry; 2018 Nov; 57(46):6528-6537. PubMed ID: 30388364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic perspectives into the mechanisms of mutation-induced p53-DNA binding loss and inactivation using active perturbation theory: Structural and molecular insights toward the design of potent reactivators in cancer therapy.
    Olotu FA; Soliman MES
    J Cell Biochem; 2019 Jan; 120(1):951-966. PubMed ID: 30160791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53-R175H mutant aggregation.
    Lei J; Cai M; Shen Y; Lin D; Deng X
    Phys Chem Chem Phys; 2021 Oct; 23(40):23032-23041. PubMed ID: 34612239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full-length p53 tetramer bound to DNA and its quaternary dynamics.
    Demir Ö; Ieong PU; Amaro RE
    Oncogene; 2017 Mar; 36(10):1451-1460. PubMed ID: 27641333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the Effect of the G245S Single Point Mutation on the Structure of p53 and the Binding of the Protein to DNA.
    Lepre MG; Omar SI; Grasso G; Morbiducci U; Deriu MA; Tuszynski JA
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28813011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plakoglobin restores tumor suppressor activity of p53
    Alaee M; Nool K; Pasdar M
    Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.
    Calhoun S; Daggett V
    Biochemistry; 2011 Jun; 50(23):5345-53. PubMed ID: 21561095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common cancer mutations R175H and R273H drive the p53 DNA-binding domain towards aggregation-prone conformations.
    Li L; Li X; Tang Y; Lao Z; Lei J; Wei G
    Phys Chem Chem Phys; 2020 May; 22(17):9225-9232. PubMed ID: 32307496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quaternary structure of the specific p53-DNA complex reveals the mechanism of p53 mutant dominance.
    Aramayo R; Sherman MB; Brownless K; Lurz R; Okorokov AL; Orlova EV
    Nucleic Acids Res; 2011 Nov; 39(20):8960-71. PubMed ID: 21764777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain.
    Wright JD; Noskov SY; Lim C
    Nucleic Acids Res; 2002 Apr; 30(7):1563-74. PubMed ID: 11917017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.
    D'Abramo M; Bešker N; Desideri A; Levine AJ; Melino G; Chillemi G
    Oncogene; 2016 Jun; 35(25):3272-81. PubMed ID: 26477317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing potential binding modes of the p53 tetramer to DNA based on the symmetries encoded in p53 response elements.
    Ma B; Levine AJ
    Nucleic Acids Res; 2007; 35(22):7733-47. PubMed ID: 17986463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in silico algorithm for identifying stabilizing pockets in proteins: test case, the Y220C mutant of the p53 tumor suppressor protein.
    Bromley D; Bauer MR; Fersht AR; Daggett V
    Protein Eng Des Sel; 2016 Sep; 29(9):377-90. PubMed ID: 27503952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53.
    Song B; Wang J; Ren Y; Su Y; Geng X; Yang F; Wang H; Zhang J
    Biomed Pharmacother; 2023 Jul; 163():114773. PubMed ID: 37156116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two p53 tetramers bind one consensus DNA response element.
    Kearns S; Lurz R; Orlova EV; Okorokov AL
    Nucleic Acids Res; 2016 Jul; 44(13):6185-99. PubMed ID: 27034469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R248Q mutation--Beyond p53-DNA binding.
    Ng JW; Lama D; Lukman S; Lane DP; Verma CS; Sim AY
    Proteins; 2015 Dec; 83(12):2240-50. PubMed ID: 26442703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of temperature on the p53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutant.
    Barakat K; Issack BB; Stepanova M; Tuszynski J
    PLoS One; 2011; 6(11):e27651. PubMed ID: 22110706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsecond molecular dynamics simulations reveal the allosteric regulatory mechanism of p53 R249S mutation in p53-associated liver cancer.
    Liu X; Tian W; Cheng J; Li D; Liu T; Zhang L
    Comput Biol Chem; 2020 Feb; 84():107194. PubMed ID: 31881526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and functionality of a designed p53 dimer.
    Davison TS; Nie X; Ma W; Lin Y; Kay C; Benchimol S; Arrowsmith CH
    J Mol Biol; 2001 Mar; 307(2):605-17. PubMed ID: 11254385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.